- About Medeon
- Our services
-
COMPANIES
-
Medeon companies
- Akutsyster
- A. MENARINI DIAGNOSTICS
- Ascelia Pharma (ALUMNI)
- Barn- och ungdomspsyk (BUP)
- LIVIO Midwifery Clinic
- Biodistra AB
- Biora AB / Straumann
- BTB Emulsions
- CheckUp (ALUMNI)
- Cleerplus
- DentalSyd
- Diabridge
- Dianovator (ALUMNI)
- Din Gravidcoach
- Ebba Biotech
- Erol AB
- Finn Medicinen (ALUMNI)
- Framtix Holdings AB
- Funwheels of Sweden AB
- GordiamKey (Alumni)
- LIVIO Fertility Centre
- Medarca
- Mercodia AB
- NanoMed North
- Nordic Center of Neurofeedback AB
- NutraGreen
- Open Lab Skåne
- Palmer psykoterapi (ALUMNI)
- PILA PHARMA
- PRENET
- Product Implementation & Development AB
- Propharma Group
- SDC Swedencare AB
- SISP Swedish Incubators & Science Parks
- Skindicator (ALUMNI)
- SmartCare Analytica AB
- Sveriges Innovationsriksdag
- Swedencare Nordic
- Tillfälligt Individanpassat Stöd (ALUMNI)
- Tonttu
- Transfer Syd
- Transunit AB
- Vibrosense Dynamics
- VITROSORB AB
- Vuxenhabiliteringen
- Yster SUP (ALUMNI)
- BTB Pharma
- Ctrl Alt Konsult
- Galenica AB
- Habilitering & Hjälpmedel
- Healthmind
- Hjälpmedel i Malmö
- Humanus Dental
- Infingent Innovations (ALUMNI)
- Innoscentia
- Innovosens
- Invitro Plant-Tech (ALUMNI)
- Kropp och Energi
- Livio Egg and Sperm Bank
- Malmö University
- Viramal
- RESTAURANT APLATE NORDIC
- ZELLACO AB
- Richter Life Science
- Brillianze Sweden
- Abarceo Pharma AB
- Go Cirkulär AB
- Junvikconsulting
- Oconeo AB
- Acutedoctor
- Bäddboken
- Lund och Diagnostics
- ConServ Sverige
- Hestia Agora
-
Medeon companies
- CONTACT
Medeonföretag
Dianovator (ALUMNI)
Dianovator AB is a start-up in diabetes technology. They develop a patient-specific decision support system for improved glycemic control by optimized insulin dosing. Their target audience is patients receiving insulin therapy using insulin pens or insulin pumps. Many of these patients experience difficulties optimizing their therapy, resulting in reduced life quality and a shorter life expectancy. Their product can help people achieve a better control, thereby reducing anxiety and lowering the risk of short and long term complications associated with poor glycemic control. Their system relies on established proven sensor technology already available on the market.
ADDRESS
Dianovator AB
Medeon Science Park
SE- 205 12 Malmö
CONTACT
Fredrik Ståhl, CEO
Mobile: +46 736 26 18 85
E-mail: fredrik.stahl@dianovator.com
Website: http://www.dianovator.se/
